(Q35648068)

English

A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients

scientific article published on December 1985

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

A randomized prospective study of ceftazidime versus ceftazidime plus flucloxacillin in the empiric treatment of febrile episodes in severely neutropenic patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1 reference

based on heuristic

inferred from title

author name string

de Pauw B

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Williams K

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

de Neeff J

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Bothof T

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

de Witte T

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Holdrinet R

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Haanen C

7

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

language of work or name

0 references

publication date

1 December 1985

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

824-828

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Comparative activities of 13 beta-lactam antibiotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180337

12 July 2018

Empiric therapy for infections in patients with granulocytopenia. Continuous v interrupted infusion of tobramycin plus cefamandole

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180337

12 July 2018

Neutropenia, fever, and infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180337

12 July 2018

Limitations of current antimicrobial therapy in the immunosuppressed host: Looking at both sides of the coin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180337

12 July 2018

Approaching the controversies in antibacterial management of cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180337

12 July 2018

Randomized study of ceftazidime versus gentamicin plus cefotaxime for infections in severe granulocytopenic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180337

12 July 2018

Septicaemia caused by viridans streptococci in neutropenic patients with leukaemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180337

12 July 2018

Colonization resistance of the digestive tract in conventional and antibiotic-treated mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180337

12 July 2018

A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180337

12 July 2018

Empiric therapy for infections in granulocytopenic cancer patients: continuous infusion of amikacin plus cephalothin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180337

12 July 2018

Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=180337

25 September 2018

Therapeutic trials with tobramycin

1 reference

https://pubmed.ncbi.nlm.nih.gov/3909956

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract

1 reference

https://pubmed.ncbi.nlm.nih.gov/3909956

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/3909956

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.28.6.824

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35648068&oldid=1582529075"